Echo IQ Ltd (ASX: EIQ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Echo IQ Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$418.59 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
740.87 million
Earnings per share
-0.028
Dividend per share
N/A
Year To Date Return
109.62%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Echo IQ Ltd (ASX: EIQ)
Latest News
Broker Notes
Buy, hold, sell: Echo IQ, Bluescope Steel, Lovisa shares
Broker Notes
Down 65%: Is it a good time to buy this exciting ASX tech stock?
Healthcare Shares
Shares surge as ASX biotech charts road to redemption
Broker Notes
Buy, hold, sell: Echo IQ, James Hardie, Woolworths shares
Broker Notes
6 ASX shares downgraded by brokers this week
Broker Notes
Morgans says these ASX shares could return 48% to 95%
Healthcare Shares
EchoIQ shares just crashed 48%. What happens now?
Healthcare Shares
Why has this ASX biotech fallen nearly 50% today?
Speculative
Morgans says these speculative ASX shares could rise 40% to 50%
Broker Notes
3 ASX shares with fresh buy ratings and big upside from Morgans
Growth Shares
This ASX growth stock is up 500% this year and set to keep rising
ASX Share Market News
What are experts saying about these red hot ASX shares?
EIQ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Echo IQ Ltd
EchoIQ Ltd. engages in the development, marketing and commercialization of software, products and services. It develops and patents algorithm dealing in Prescriptive Analytics. The company was founded by Richard Charles Anstey on March 31, 2010 and is headquartered in Sydney, Australia.
EIQ Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 07 Oct 2026 | $0.57 | $0.02 | 3.67% | 4,166,883 | $0.54 | $0.60 | $0.54 |
| 06 Oct 2026 | $0.55 | $-0.01 | -1.80% | 2,852,297 | $0.57 | $0.57 | $0.54 |
| 05 Oct 2026 | $0.56 | $-0.02 | -3.45% | 2,481,954 | $0.58 | $0.59 | $0.56 |
| 02 Oct 2026 | $0.58 | $0.01 | 1.75% | 1,922,135 | $0.59 | $0.60 | $0.57 |
| 01 Oct 2026 | $0.57 | $-0.03 | -5.00% | 3,537,523 | $0.62 | $0.62 | $0.57 |
| 30 Sep 2026 | $0.60 | $0.05 | 9.17% | 5,455,239 | $0.57 | $0.62 | $0.55 |
| 29 Sep 2026 | $0.55 | $0.01 | 1.85% | 5,741,969 | $0.55 | $0.57 | $0.54 |
| 28 Sep 2026 | $0.54 | $-0.05 | -8.47% | 6,998,875 | $0.59 | $0.59 | $0.54 |
| 25 Sep 2026 | $0.59 | $-0.08 | -11.94% | 11,481,317 | $0.66 | $0.66 | $0.58 |
| 24 Sep 2026 | $0.67 | $0.03 | 4.69% | 8,573,846 | $0.65 | $0.70 | $0.65 |
| 23 Sep 2026 | $0.64 | $-0.02 | -3.05% | 3,732,788 | $0.65 | $0.68 | $0.63 |
| 22 Sep 2026 | $0.66 | $-0.05 | -7.04% | 9,764,216 | $0.71 | $0.72 | $0.62 |
| 21 Sep 2026 | $0.71 | $-0.07 | -9.03% | 23,978,030 | $0.74 | $0.85 | $0.69 |
| 18 Sep 2026 | $0.78 | $0.19 | 32.20% | 45,753,628 | $0.61 | $0.79 | $0.60 |
| 17 Sep 2026 | $0.59 | $0.07 | 13.59% | 13,230,652 | $0.52 | $0.61 | $0.52 |
| 16 Sep 2026 | $0.52 | $-0.03 | -5.56% | 11,403,339 | $0.55 | $0.57 | $0.52 |
| 15 Sep 2026 | $0.54 | $0.06 | 12.37% | 11,085,381 | $0.47 | $0.54 | $0.47 |
| 14 Sep 2026 | $0.49 | $-0.03 | -5.83% | 7,993,387 | $0.52 | $0.53 | $0.48 |
| 11 Sep 2026 | $0.52 | $-0.05 | -8.77% | 17,399,526 | $0.55 | $0.56 | $0.48 |
| 10 Sep 2026 | $0.57 | $-0.07 | -10.94% | 15,555,802 | $0.60 | $0.65 | $0.54 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 09 Apr 2026 | Steven Formica | Issued | 625,000 | $562,500 |
Conversion of securities.
|
| 09 Apr 2026 | Steven Formica | Exercise | 625,000 | $562,500 |
Conversion of securities. 1,875,000 Performance Rights
|
| 09 Apr 2026 | Andrew Grover | Exercise | 1,000,000 | $900,000 |
Conversion of securities. 3,000,000 Performance Rights
|
| 09 Apr 2026 | Andrew Grover | Issued | 1,000,000 | $900,000 |
Conversion of securities.
|
| 11 Mar 2026 | Andrew Grover | Exercise | 1,000,000 | $725,000 |
Conversion of securities. 4,000,000 Performance Rights
|
| 11 Mar 2026 | Andrew Grover | Issued | 1,000,000 | $725,000 |
Conversion of securities.
|
| 11 Mar 2026 | Steven Formica | Exercise | 625,000 | $453,125 |
Conversion of securities. 2,500,000 Performance Rights
|
| 11 Mar 2026 | Steven Formica | Issued | 625,000 | $453,125 |
Conversion of securities.
|
| 20 Feb 2026 | Andrew Grover | Exercise | 1,000,000 | $575,000 |
Conversion of securities. 5,000,000 Performance Rights
|
| 20 Feb 2026 | Andrew Grover | Issued | 1,000,000 | $575,000 |
Conversion of securities.
|
| 20 Feb 2026 | Steven Formica | Exercise | 625,000 | $359,375 |
Conversion of securities. 3,125,000 Performance Rights
|
| 20 Feb 2026 | Steven Formica | Issued | 625,000 | $359,375 |
Conversion of securities.
|
| 30 Jan 2026 | Steven Formica | Exercise | 625,000 | $309,375 |
Conversion of securities. 3,750,000 Performance Rights
|
| 30 Jan 2026 | Steven Formica | Issued | 625,000 | $309,375 |
Conversion of securities.
|
| 30 Jan 2026 | Andrew Grover | Exercise | 1,000,000 | $495,000 |
Conversion of securities. 6,000,000 Performance Rights
|
| 30 Jan 2026 | Andrew Grover | Issued | 1,000,000 | $495,000 |
Conversion of securities.
|
| 31 Dec 2025 | Steven Formica | Expiry | 625,000 | $162,500 |
As advised by the company. 4,375,000 Performance Rights, Lapsed
|
| 31 Dec 2025 | Andrew Grover | Expiry | 1,000,000 | $260,000 |
As advised by the company. 7,000,000 Performance Rights, lapsed
|
| 08 Dec 2025 | Stephen (Steve) Picton | Expiry | 2,000,000 | $500,000 |
Options expired.
|
| 08 Dec 2025 | Steven Formica | Expiry | 1,650,000 | $412,500 |
Options expired.
|
| 08 Dec 2025 | Andrew Grover | Expiry | 4,850,000 | $1,212,500 |
Options expired. As per announcement on 09-12-2025
|
| 09 Oct 2025 | Stephen (Steve) Picton | Buy | 1,250,000 | $227,757 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Stephen (Steve) Picton | Non-Executive Director | Oct 2021 |
Mr Picton has over 35 years of experience in the technology industry having held senior positions in British Telecom (BT) and AAPT prior to him forming gotalk and relaunching LBNCo.
|
| Mr Steven Allen Formica | Non-Executive Director | Jul 2018 |
Mr Formica is an experienced company director with more than 30 years of commercial, operational and governance experience across private businesses. He has overseen and expanded enterprises across retail, industrial, manufacturing, construction, logistics, property development, resources (exploration and operations), health and technology bringing a practical capability in business development, strategic planning and operational leadership.
|
| Mr Andrew Richard Grover | Executive ChairmanExecutive Director | May 2019 |
Mr Grover is an experienced business entrepreneur and investor with more than 30 years of experience across management, business development, sales and marketing, technology and corporate strategy. Throughout his career, Andrew has founded, built and invested in several businesses. He has completed multiple business exits and has advised and consulted a range of medium-sized companies. Andrew also mentors several CEOs and senior executives, drawing on his experience in building, scaling and leading businesses.
|
| Mr Ken Nelson | Non-Executive Director | Dec 2024 |
Mr Nelson is a commercial innovator in the field of cardiac digital health and remote patient monitoring and has led commercial efforts for technologies in digital health, wearables, and cardiac remote patient monitoring industries, building and leading teams and cultures. Overall, he is a 25-year digital health, medical device, and remote patient monitoring executive and innovator with senior leadership experience. He also previously served as Head of Digital Health, Diagnostics, and Monitoring for Biotronik, a cardiac digital health and implantable medical device company.
|
| Mr Scott Wilkin | Non-Executive Director | Sep 2026 |
Mr Wilkin has 35 years of global investment and healthcare sector experience. Mr Wilkin served as Managing Director of Medical Technology Institutional Research at SG Cowen Securities and Director of Medical Technology Institutional Research at UBS Warburg.
|
| Ms Jessamyn Sarah Lyons | Company Secretary | Oct 2021 |
-
|
| Mr Dustin Haines | Chief Executive Officer | Jan 2025 |
-
|
| Matthew Dodds | CFO |
-
|
|
| Dustin Haines | Chief Executive Officer |
-
|
|
| Jessamyn Sarah Lyons | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Citicorp Nominees Pty Limited | 84,798,379 | 11.45% |
| J P Morgan Nominees Australia Pty Limited | 49,315,483 | 6.66% |
| Stevsand Investments Pty Ltd <Steven Formica Family A/C> | 29,600,000 | 4.00% |
| A22 Pty Ltd | 28,000,000 | 3.78% |
| HSBC Custody Nominees (Australia) Limited | 20,039,784 | 2.71% |
| Heath Nominees (Aust) Pty Ltd <The Heath Family A/C> | 11,715,923 | 1.58% |
| Mr Brian Joseph Glynn | 11,300,000 | 1.53% |
| Jpw Holdings Pty Ltd <Jpw Family A/C> | 11,000,000 | 1.49% |
| Ms Laura Bailey | 8,250,000 | 1.11% |
| BNP Paribas Nominees Pty Ltd <IB Au Noms Retailclient> | 7,535,822 | 1.02% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 5,921,851 | 0.80% |
| Mr Muthiah John Hilbert | 4,500,000 | 0.61% |
| First One Realty Pty Ltd | 4,454,238 | 0.60% |
| Kli Pty Ltd <The T Teh Family A/C> | 4,300,000 | 0.58% |
| Alerte Digital Health Pte Ltd | 4,044,047 | 0.55% |
| Thorney International Pty Ltd | 1,415,217 | 1.04% |
| Grandalbero Pty Ltd <The Thompson Family A/C> | 1,263,481 | 0.93% |
| Lytton Nominees Pty Ltd <Lytton Super Fund A/C> | 1,021,418 | 0.75% |
| Sandhurst Trustees Ltd <Millex Ethical Fund A/C> | 1,000,000 | 0.74% |
| Kaynadan Pty Ltd <The Bower Family A/C> | 890,510 | 0.66% |
